GO:1903530 regulation of secretion by cell: Cellular Secretion Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903530 (regulation of secretion by cell) is a biological process that modulates the frequency, rate or extent of secretion by a cell [1,6].
• It governs the release of ions, acids, hormones, enzymes, and neurotransmitters from specialized secretory cells such as gastric parietal cells, pancreatic islet cells, and hepatocytes [1,2,4].
• Dysregulation of secretion underlies major diseases including type 2 diabetes, asthma, cholestasis, and adrenal disorders [3,5,8].
• Key regulatory inputs include calcium signaling, zinc homeostasis, neural and endocrine feedback, and paracrine peptides [2,3,4,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of secretion-regulating genes [3,5].
• Single-cell and population transcriptomics reveal pan-epithelial remodeling of secretory programs in disease states such as type 2-high asthma.
Description
Regulation of secretion by cell (GO:1903530) is a fundamental biological process that controls how much, how fast, and how often a cell releases substances into its environment or into the bloodstream [1,6]. Secretion is not a passive leak; it is actively tuned by neural, hormonal, paracrine, and metabolic signals that converge on ion channels, transporters, and exocytotic machinery [2,7]. This GO term captures any process that modulates the frequency, rate, or extent of cellular secretion, making it a central node for understanding both normal physiology and disease [1,4].
regulation of secretion by cell At A Glance
| GO ID | GO:1903530 |
|---|---|
| GO term | regulation of secretion by cell |
| Ontology | biological_process |
| Synonym | regulation of cellular secretion |
| Definition | Any process that modulates the frequency, rate or extent of secretion by cell. |
| Major function | Controls the timing, amount, and composition of secreted molecules from cells. |
| Representative cell types | Gastric parietal cells, pancreatic alpha and beta cells, hepatocytes, airway epithelial cells, adrenal cortical cells. |
| Key regulatory inputs | Calcium signaling, zinc homeostasis, neural and endocrine feedback, paracrine peptides. |
| Disease relevance | Type 2 diabetes, asthma, cholestasis, adrenal disorders, gastric acid-related disease. |
What Is GO:1903530?
GO:1903530, regulation of secretion by cell, is defined as any process that modulates the frequency, rate or extent of secretion by cell. In practical terms, it includes the signaling cascades, ion fluxes, and molecular checkpoints that determine whether a secretory cell releases its cargo and how much it releases. It is a biological process term that sits above more specific child terms such as regulation of gastric acid secretion, regulation of insulin secretion, and regulation of bile secretion [1,4,6].
Why Is regulation of secretion by cell Important in Cell Biology?
Regulation of secretion by cell is important because secreted molecules such as acid, insulin, glucagon, cortisol, bile, and inflammatory mediators must be released in precise amounts to maintain homeostasis [1,2,4,6]. When this regulation fails, the consequences range from metabolic disease to chronic inflammation and organ damage [3,5,8]. Understanding GO:1903530 therefore provides a mechanistic entry point for therapeutic strategies that aim to restore or dampen secretion in a cell-type-specific manner [2,4,8].
• Controls gastric acid output by parietal cells, with direct implications for peptic ulcer disease and acid-related disorders [1,6,7].
• Regulates insulin and glucagon secretion from pancreatic islets, central to glucose homeostasis and type 2 diabetes [3,8].
• Modulates cortisol and ACTH secretion rhythms, relevant to adrenal and stress-related disease.
• Governs bile secretion by hepatocytes, linking calcium signaling to cholestatic liver disease.
• Shapes airway epithelial secretory programs in type 2-high asthma.
• Provides mechanistic targets for drugs that stimulate or inhibit secretion [2,7].
• Enables causal gene discovery through CRISPR knockout and knock-in models [3,5].
• Connects single-cell transcriptomics to functional secretory phenotypes.
• Informs biomarker discovery for endocrine and metabolic disorders [2,8].
• Supports development of cell-type-specific secretion modulators [1,4].
What Happens During regulation of secretion by cell?
Signal reception and integration
In simple terms: The cell first listens to signals telling it whether to release substances.
Secretory cells receive neural, hormonal, and paracrine inputs that are integrated before a secretory response is triggered [2,7]. In gastric parietal cells, acetylcholine, gastrin, and histamine converge on distinct receptors to regulate acid secretion [1,6]. In pancreatic islets, glucose, zinc, and islet peptides modulate beta cell and alpha cell secretion [3,8]. This integration step determines whether the cell will secrete and at what magnitude [2,7].
Calcium signaling and second messengers
In simple terms: Calcium acts as an internal switch that turns secretion on or off.
Calcium signaling is a central regulator of secretion across cell types. In hepatocytes, calcium signals regulate bile secretion in health and disease. In endocrine cells, calcium entry triggers exocytosis of hormone-containing granules [2,8]. Second messengers such as cAMP and inositol trisphosphate amplify or dampen these calcium signals, shaping the frequency and extent of secretion [4,7].
Vesicle trafficking and exocytosis
In simple terms: Packages of secretory cargo are moved to the cell surface and released.
Once a secretory signal is integrated, cargo-containing vesicles are trafficked to the plasma membrane and undergo exocytosis [1,7]. In parietal cells, tubulovesicular membranes fuse with the apical membrane to deliver proton pumps during acid secretion [1,6]. In pancreatic beta cells, insulin granules fuse with the plasma membrane in response to calcium and metabolic signals [3,8]. This step is tightly regulated to match cargo release with physiological demand [1,7].
Feedback and termination
In simple terms: The cell shuts down secretion once the job is done.
Secretion is terminated by negative feedback loops that prevent excessive release [2,6]. In the hypothalamic-pituitary-adrenal axis, cortisol feeds back to suppress ACTH secretion, maintaining ultradian and circadian rhythms. In the stomach, acid-induced somatostatin release inhibits further gastric acid secretion. These feedback mechanisms are essential for avoiding hypersecretory or hyposecretory states [2,6].
Cell-type-specific secretory programs
In simple terms: Different cells have different secretion jobs, controlled by distinct gene programs.
Single-cell and population transcriptomics have revealed that secretory programs are cell-type-specific and can be remodeled in disease. In type 2-high asthma, pan-epithelial remodeling alters secretory gene expression across airway epithelial cell subsets. This heterogeneity means that regulation of secretion by cell must be studied in the relevant cellular context.
Key Genes Involved in GO:1903530 regulation of secretion by cell
The following genes and proteins are experimentally implicated in regulation of secretion by cell across gastric, pancreatic, hepatic, adrenal, and airway systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATP4A | Gastric H+/K+-ATPase alpha subunit; drives acid secretion in parietal cells | Target for acid suppression studies and parietal cell knockout models [1,6] |
| ATP4B | Gastric H+/K+-ATPase beta subunit; partners with ATP4A | Used to dissect proton pump assembly and secretory membrane trafficking |
| SLC30A8 (ZnT8) | Zinc transporter in pancreatic beta cells; regulates insulin granule zinc content | Beta cell-specific knockout mouse links zinc to glucagon and insulin secretion |
| GCG | Glucagon precursor; secreted by pancreatic alpha cells | Central to glucose counter-regulation and type 2 diabetes research |
| INS | Insulin; secreted by pancreatic beta cells | Readout for beta cell secretory function and diabetes models [3,8] |
| POMC | Pro-opiomelanocortin; precursor to ACTH and other peptides | Used to study ACTH secretion dynamics and adrenal disease |
| CRH | Corticotropin-releasing hormone; drives ACTH secretion | Key node in hypothalamic-pituitary-adrenal axis regulation |
| SSTR2 | Somatostatin receptor; inhibits gastric acid secretion | Target for feedback regulation studies in stomach |
| GAST | Gastrin; stimulates gastric acid secretion | Used to model endocrine control of parietal cell secretion [1,6] |
| CHRM3 | Muscarinic acetylcholine receptor M3; mediates vagal stimulation of acid secretion | Knockout models reveal neural control of secretion [1,7] |
| HRH2 | Histamine H2 receptor; stimulates acid secretion | Pharmacological and genetic target for acid suppression [1,6] |
| CFTR | Chloride channel; regulates epithelial fluid and anion secretion | Relevant to airway and hepatobiliary secretion studies [4,5] |
| SLC4A2 | Anion exchanger in hepatocytes; contributes to bile secretion | Used to study calcium-dependent bile secretion |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor; mediates calcium release | Central to calcium signaling in secretion |
| STIM1 | Calcium sensor; activates store-operated calcium entry | Modulates sustained secretory responses |
| ORAI1 | Store-operated calcium channel; supports calcium influx | Used to dissect calcium-dependent secretion |
| SNAP25 | SNARE protein; mediates vesicle fusion during exocytosis | Core exocytosis machinery for secretion studies [1,7] |
| STXBP1 | MUNC18-1; regulates SNARE-mediated vesicle fusion | Target for exocytosis regulation experiments [1,7] |
How Is regulation of secretion by cell Regulated?
Regulation of secretion by cell is itself regulated at multiple levels. Neural inputs such as vagal stimulation control gastric acid secretion through muscarinic receptors [1,7]. Endocrine feedback, including cortisol suppression of ACTH, sets the frequency and amplitude of secretory pulses. Paracrine peptides such as somatostatin terminate secretory bursts in the stomach. Metabolic signals, including glucose and zinc, tune insulin and glucagon secretion in pancreatic islets [3,8]. Calcium signaling acts as a convergent regulator across hepatocytes and endocrine cells. Together, these layers ensure that secretion is matched to physiological demand [2,4,6].
regulation of secretion by cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC30A8 (ZnT8) | Type 2 diabetes; zinc-dependent regulation of glucagon and insulin secretion | Beta cell-specific knockout mouse |
| POMC | Adrenal disorders; dysregulated ACTH and cortisol secretion | Knockout or knock-in models of POMC processing |
| ATP4A | Gastric acid-related disease; peptic ulcer biology | Parietal cell knockout or point-mutation models [1,6] |
| CFTR | Cholestasis and airway secretion disorders | Knock-in or knockout epithelial cell models [4,5] |
| GCG | Type 2 diabetes; alpha cell secretion dysfunction | Alpha cell-specific knockout or overexpression models |
Metabolic and endocrine disease
Dysregulated insulin and glucagon secretion is a hallmark of type 2 diabetes [3,8]. The beta cell-specific Znt8 knockout mouse has been used to show that zinc transport regulates glucagon secretion, linking granule zinc content to islet hormone release. Islet peptides are actively investigated as modulators of beta cell function and as therapeutic candidates in type 2 diabetes. Abnormal ACTH and cortisol secretion dynamics are also implicated in adrenal and stress-related disorders.
Gastrointestinal and hepatobiliary disease
Gastric acid secretion by parietal cells is a major determinant of peptic ulcer disease and acid-related disorders [1,6,7]. Calcium signaling in hepatocytes regulates bile secretion, and its disruption contributes to cholestatic liver disease. Understanding the regulatory inputs to parietal cells and hepatocytes supports the development of targeted secretion-modulating therapies [1,4,6].
Airway and inflammatory disease
Single-cell and population transcriptomics have revealed pan-epithelial remodeling in type 2-high asthma, including changes in secretory programs across airway epithelial cells. This suggests that regulation of secretion by cell contributes to mucus and mediator release in asthma, and that epithelial secretory states may be therapeutically relevant.
From regulation of secretion by cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene alter regulated secretion? | CRISPR knockout in the relevant secretory cell line or primary cell model [3,5] |
| Does a specific amino acid change affect secretory regulation? | Point-mutation knock-in using CRISPR |
| Can a reporter track secretion in real time? | Tagged knock-in of a secretory cargo or regulatory protein [1,4] |
| Does overexpression of a regulator enhance or suppress secretion? | CRISPR-mediated overexpression or cDNA overexpression |
| Which genes control cell-type-specific secretory programs? | CRISPR library screening combined with single-cell transcriptomics |
| How do calcium signaling components modulate secretion? | Knockout or point-mutation models of ITPR1, STIM1, ORAI1 |
How to Study the regulation of secretion by cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Cell-type-specific secretory gene programs | Airway epithelial remodeling in asthma |
| Calcium imaging | Intracellular calcium dynamics | Calcium-dependent bile and hormone secretion |
| Insulin/glucagon secretion assays | Hormone release from islet cells | Beta cell and alpha cell function in diabetes models [3,8] |
| ACTH/cortisol assays | Pulsatile hormone secretion | Adrenal and stress axis studies |
| Gastric acid secretion assays | Acid output from parietal cells | Gastric physiology and pharmacology [1,6,7] |
| CRISPR knockout | Loss-of-function effects on secretion | Causal gene discovery in secretory cells [3,5] |
| CRISPR knock-in | Effects of specific mutations or tags | Point-mutation and reporter studies [3,4] |
| CRISPR library screening | Pooled gene effects on secretory phenotypes | High-throughput regulator discovery |
Transcriptomic profiling of secretory programs
Single-cell and population transcriptomics can reveal how secretory gene programs are remodeled across cell types and disease states. In type 2-high asthma, this approach identified pan-epithelial remodeling of secretory genes. Such datasets help prioritize candidate regulators of secretion for functional testing.
Calcium imaging and signaling assays
Calcium signaling is a central regulator of secretion, and calcium imaging can be used to measure stimulus-evoked calcium changes in secretory cells. These assays are particularly informative in hepatocytes and endocrine cells where calcium controls bile and hormone release.
Hormone and metabolite secretion assays
Direct measurement of secreted products such as insulin, glucagon, cortisol, and acid equivalents provides functional readouts of regulation of secretion by cell [2,3,6]. These assays can be combined with genetic perturbation to establish causality [3,8].
Genetic and pharmacological perturbation
Knockout, knock-in, and overexpression models allow researchers to test whether a candidate gene causally regulates secretion [3,5]. Pharmacological tools targeting receptors such as HRH2 and CHRM3 complement genetic approaches in gastric acid secretion studies [1,6,7].
How CRISPR Can Be Used to Study GO:1903530 regulation of secretion by cell
Knockout
CRISPR knockout is used to delete candidate regulators of secretion and measure the resulting change in secretory output [3,5]. For example, beta cell-specific knockout of SLC30A8 (ZnT8) revealed a role for zinc in regulating glucagon secretion. Knockout approaches are also valuable for dissecting calcium signaling components in hepatocytes.
Point Mutation
Point-mutation models allow researchers to test whether specific residues or domains are required for regulation of secretion by cell. This is particularly useful when complete knockout is lethal or when a subtle change in protein function is suspected [3,4].
Knock-in
Knock-in strategies can introduce reporters, tags, or human disease variants into secretory cells to track secretion in real time or model disease-associated mutations [1,4]. Tagged knock-in of secretory cargo or regulatory proteins enables imaging of vesicle trafficking and exocytosis [1,7].
Overexpression
CRISPR-mediated overexpression or cDNA overexpression can test whether increasing the level of a candidate regulator enhances or suppresses secretion. This complements loss-of-function studies and helps establish sufficiency in secretion regulation.
How EDITGENE Supports regulation of secretion by cell Research
Researchers studying regulation of secretion by cell-related genes often need to determine whether a candidate gene is causally involved in controlling the frequency, rate, or extent of secretion. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbation of secretory pathways in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for regulation of secretion by cell research.
Frequently Asked Questions About regulation of secretion by cell
What is GO:1903530 regulation of secretion by cell?
GO:1903530 is a biological process term defined as any process that modulates the frequency, rate or extent of secretion by cell [1,6].
What genes are involved in regulation of secretion by cell?
Genes such as ATP4A, ATP4B, SLC30A8, GCG, INS, POMC, CRH, and CFTR are experimentally implicated in regulating secretion across gastric, pancreatic, adrenal, and epithelial cells [1,2,3,4,8].
How is gastric acid secretion regulated?
Gastric acid secretion is regulated by neural, hormonal, and paracrine inputs including acetylcholine, gastrin, histamine, and somatostatin acting on parietal cells [1,6,7].
What role does calcium play in secretion?
Calcium signaling is a central regulator of secretion, including bile secretion in hepatocytes and hormone release in endocrine cells.
How does zinc affect insulin and glucagon secretion?
The beta cell-specific Znt8 knockout mouse has been used to show that zinc transport regulates glucagon secretion, linking granule zinc content to islet hormone release.
What diseases are linked to dysregulated secretion?
Dysregulated secretion is linked to type 2 diabetes, asthma, cholestasis, adrenal disorders, and gastric acid-related disease [2,3,4,5,6].
How can CRISPR be used to study regulation of secretion by cell?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes in secretory cells [3,4,5,8].
What methods measure regulated secretion?
Methods include single-cell RNA-seq, calcium imaging, hormone secretion assays, gastric acid assays, and CRISPR-based perturbation [1,2,3,4,5].
What is the role of ACTH and cortisol secretion dynamics?
ACTH and cortisol are secreted in dynamic pulses, and their regulation is important for adrenal and stress-related disease research.
How does type 2-high asthma relate to secretion?
Single-cell and population transcriptomics reveal pan-epithelial remodeling in type 2-high asthma, including changes in secretory programs.
Conclusion
GO:1903530 regulation of secretion by cell is a central biological process that controls how cells release ions, hormones, enzymes, and other cargo in response to physiological demand [1,6]. Its dysregulation contributes to major diseases including type 2 diabetes, asthma, cholestasis, and gastric acid-related disorders [2,3,4,5,6]. CRISPR-based cell models and transcriptomic methods provide powerful tools to dissect the causal genes and pathways that regulate secretion, supporting both mechanistic discovery and therapeutic development [3,4,5,8].
References
- 1. Engevik AC et al.. 2020. The Physiology of the Gastric Parietal Cell.. Physiol Rev 100(2):573-602 PMID: 31670611
- 2. Lightman SL et al.. 2020. Dynamics of ACTH and Cortisol Secretion and Implications for Disease.. Endocr Rev 41(3) PMID: 32060528
- 3. Hardy AB et al.. 2011. Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model.. Diabetes Obes Metab 13 Suppl 1:112-7 PMID: 21824264
- 4. Trampert DC et al.. 2018. Regulation of bile secretion by calcium signaling in health and disease.. Biochim Biophys Acta Mol Cell Res 1865(11 Pt B):1761-1770 PMID: 29787781
- 5. Jackson ND et al.. 2020. Single-Cell and Population Transcriptomics Reveal Pan-epithelial Remodeling in Type 2-High Asthma.. Cell Rep 32(1):107872 PMID: 32640237
- 6. Schubert ML. 2010. Gastric secretion.. Curr Opin Gastroenterol 26(6):598-603 PMID: 20838342
- 7. Soll AH et al.. 1979. Regulation of gastric acid secretion.. Annu Rev Physiol 41:35-53 PMID: 219762
- 8. Khan D et al.. 2018. Role of islet peptides in beta cell regulation and type 2 diabetes therapy.. Peptides 100:212-218 PMID: 29412821
